BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 22321728)

  • 1. Reconciling the nutritional and glucocorticoid hypotheses of fetal programming.
    Cottrell EC; Holmes MC; Livingstone DE; Kenyon CJ; Seckl JR
    FASEB J; 2012 May; 26(5):1866-74. PubMed ID: 22321728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sexually dimorphic effects of maternal dietary protein restriction on fetal growth and placental expression of 11β-HSD2 in the pig.
    Shang Y; Jia Y; Sun Q; Shi W; Li R; Wang S; Sui S; Zhao R
    Anim Reprod Sci; 2015 Sep; 160():40-8. PubMed ID: 26205550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethanol-induced inhibition of fetal hypothalamic-pituitary-adrenal axis due to prenatal overexposure to maternal glucocorticoid in mice.
    Liang G; Chen M; Pan XL; Zheng J; Wang H
    Exp Toxicol Pathol; 2011 Nov; 63(7-8):607-11. PubMed ID: 20627497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foetal and placental 11β-HSD2: a hub for developmental programming.
    Cottrell EC; Seckl JR; Holmes MC; Wyrwoll CS
    Acta Physiol (Oxf); 2014 Feb; 210(2):288-95. PubMed ID: 24330050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoids, 11beta-hydroxysteroid dehydrogenase, and fetal programming.
    Seckl JR; Cleasby M; Nyirenda MJ
    Kidney Int; 2000 Apr; 57(4):1412-7. PubMed ID: 10760076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression patterns of the 11β-hydroxysteroid dehydrogenase 2 enzyme in human placenta from intrauterine growth restriction: the role of impaired feto-maternal glucocorticoid metabolism.
    Börzsönyi B; Demendi C; Pajor A; Rigó J; Marosi K; Agota A; Nagy ZB; Joó JG
    Eur J Obstet Gynecol Reprod Biol; 2012 Mar; 161(1):12-7. PubMed ID: 22239940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of placental 11β-HSD2 induced by high maternal glucocorticoid exposure mediates sex differences in placental and fetal development.
    Yu P; Zhou J; Ge C; Fang M; Zhang Y; Wang H
    Sci Total Environ; 2022 Jun; 827():154396. PubMed ID: 35259391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid programming.
    Seckl JR; Meaney MJ
    Ann N Y Acad Sci; 2004 Dec; 1032():63-84. PubMed ID: 15677396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered placental function of 11beta-hydroxysteroid dehydrogenase 2 knockout mice.
    Wyrwoll CS; Seckl JR; Holmes MC
    Endocrinology; 2009 Mar; 150(3):1287-93. PubMed ID: 18845627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal fetomaternal glucocorticoid metabolism in the background of premature delivery: placental expression patterns of the 11β-hydroxysteroid dehydrogenase 2 gene.
    Demendi C; Börzsönyi B; Pajor A; Rigó J; Nagy ZB; Szentpéteri I; Joó JG
    Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):210-4. PubMed ID: 22959142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of disease: glucocorticoids, their placental metabolism and fetal 'programming' of adult pathophysiology.
    Seckl JR; Holmes MC
    Nat Clin Pract Endocrinol Metab; 2007 Jun; 3(6):479-88. PubMed ID: 17515892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosterone transfer and metabolism in the dually perfused rat placenta: effect of 11beta-hydroxysteroid dehydrogenase type 2.
    Staud F; Mazancová K; Miksík I; Pávek P; Fendrich Z; Pácha J
    Placenta; 2006; 27(2-3):171-80. PubMed ID: 16338462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placental 11beta-hydroxysteroid dehydrogenase type 2 is reduced in pregnancies complicated with idiopathic intrauterine growth Restriction: evidence that this is associated with an attenuated ratio of cortisone to cortisol in the umbilical artery.
    Dy J; Guan H; Sampath-Kumar R; Richardson BS; Yang K
    Placenta; 2008 Feb; 29(2):193-200. PubMed ID: 18061258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placental 11beta-HSD2 activity, early postnatal clinical course, and adrenal function in extremely low birth weight infants.
    Kajantie E; Dunkel L; Turpeinen U; Stenman UH; Andersson S
    Pediatr Res; 2006 Apr; 59(4 Pt 1):575-8. PubMed ID: 16549532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antenatal exposure to betamethasone induces placental 11β-hydroxysteroid dehydrogenase type 2 expression and the adult metabolic disorders in mice.
    Ni L; Pan Y; Tang C; Xiong W; Wu X; Zou C
    PLoS One; 2018; 13(9):e0203802. PubMed ID: 30212527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal brain 11β-hydroxysteroid dehydrogenase type 2 selectively determines programming of adult depressive-like behaviors and cognitive function, but not anxiety behaviors in male mice.
    Wyrwoll C; Keith M; Noble J; Stevenson PL; Bombail V; Crombie S; Evans LC; Bailey MA; Wood E; Seckl JR; Holmes MC
    Psychoneuroendocrinology; 2015 Sep; 59():59-70. PubMed ID: 26036451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pravastatin ameliorates placental vascular defects, fetal growth, and cardiac function in a model of glucocorticoid excess.
    Wyrwoll CS; Noble J; Thomson A; Tesic D; Miller MR; Rog-Zielinska EA; Moran CM; Seckl JR; Chapman KE; Holmes MC
    Proc Natl Acad Sci U S A; 2016 May; 113(22):6265-70. PubMed ID: 27185937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cold exposure on the levels of glucocorticoids, 11-hydroxysteroid dehydrogenase 2, and placental vascularization in a rat model.
    Zhang QJ; Chen SW; Xu X; Zhang HL; Yan JY
    Eur Rev Med Pharmacol Sci; 2023 Dec; 27(24):11961-11974. PubMed ID: 38164859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced placental 11beta-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms.
    McTernan CL; Draper N; Nicholson H; Chalder SM; Driver P; Hewison M; Kilby MD; Stewart PM
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4979-83. PubMed ID: 11600574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhythm of Fetoplacental 11β-Hydroxysteroid Dehydrogenase Type 2 - Fetal Protection From Morning Maternal Glucocorticoids.
    Lamadé EK; Hendlmeier F; Wudy SA; Witt SH; Rietschel M; Coenen M; Gilles M; Deuschle M
    J Clin Endocrinol Metab; 2021 May; 106(6):1630-1636. PubMed ID: 33621325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.